Related Experiment Video
Updated: Mar 23, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Antibiotics and antiseptics for pressure ulcers
Gill Norman1, Jo C Dumville, Zena E H Moore
1School of Nursing, Midwifery and Social Work, University of Manchester, Jean McFarlane Building, Oxford Road, Manchester, UK, M13 9PL.
The effectiveness of topical antiseptics and antibiotics for treating pressure ulcers remains unclear. Some evidence suggests certain antiseptics may hinder healing compared to non-antimicrobial options, necessitating further research.
Area of Science:
- Wound healing research
- Dermatology
- Infectious disease management
Background:
- Pressure ulcers (bedsores) are localized skin injuries requiring effective treatment.
- Antimicrobial therapies, including antiseptics and antibiotics, are commonly used for pressure ulcer management.
- A comprehensive overview of current evidence is needed to guide clinical decisions.
Purpose of the Study:
- To evaluate the impact of systemic and topical antibiotics and topical antiseptics on pressure ulcer healing.
- To assess these treatments in both infected and uninfected pressure ulcers across various clinical settings.
Main Methods:
- Systematic search of multiple databases (Cochrane Wounds, CENTRAL, MEDLINE, EMBASE, CINAHL) and trial registries up to October 2015.
- Inclusion of randomized controlled trials (RCTs) involving adults with Stage II or higher pressure ulcers.
- Independent study selection, risk of bias assessment, and data extraction by two reviewers.
Main Results:
- Twelve RCTs (576 participants) assessed topical agents; no trials evaluated systemic antibiotics.
- Povidone iodine showed potential for reduced short-term healing compared to non-antimicrobial dressings.
- Evidence quality ranged from moderate to very low, with small trial sizes and short follow-up periods.
Conclusions:
- The comparative efficacy of antimicrobial treatments for pressure ulcers is not well-established.
- Some evidence suggests non-antimicrobial treatments may be more effective than certain antiseptics.
- Limitations include small sample sizes, heterogeneity, and high/unclear risk of bias across included trials.
More Related Videos
09:37Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings
Published on: December 4, 2021
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
Related Concept Videos
Hand hygiene
Hand washing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy